<VariationArchive VariationID="4535" VariationName="NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs)" VariationType="Deletion" Accession="VCV000004535" Version="27" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="4" DateLastUpdated="2024-07-15" DateCreated="2015-05-08" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19574" VariationID="4535">
      <GeneList>
        <Gene Symbol="BSCL2" FullName="BSCL2 lipid droplet biogenesis associated, seipin" GeneID="26580" HGNC_ID="HGNC:15832" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62709537" display_start="62690262" display_stop="62709537" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62457733" stop="62477090" display_start="62457733" display_stop="62477090" Strand="-" />
          </Location>
          <OMIM>606158</OMIM>
        </Gene>
        <Gene Symbol="HNRNPUL2-BSCL2" FullName="HNRNPUL2-BSCL2 readthrough (NMD candidate)" GeneID="100534595" HGNC_ID="HGNC:49189" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62727384" display_start="62690262" display_stop="62727384" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs)</Name>
      <CanonicalSPDI>NC_000011.10:62694684:ACGATACG:ACG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62694685" stop="62694689" display_start="62694685" display_stop="62694689" variantLength="5" positionVCF="62694684" referenceAlleleVCF="CACGAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62462157" stop="62462161" display_start="62462157" display_stop="62462161" variantLength="5" positionVCF="62462156" referenceAlleleVCF="CACGAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Y170fs</ProteinChange>
      <ProteinChange>Y106fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.62694688_62694692del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.62694688_62694692del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.62462160_62462164del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.62462160_62462164del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008461.1" sequenceAccession="NG_008461" sequenceVersion="1" change="g.19886_19890del">
            <Expression>NG_008461.1:g.19886_19890del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033077.1" sequenceAccession="NG_033077" sequenceVersion="1" change="g.211_215del">
            <Expression>NG_033077.1:g.211_215del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037946.1" sequenceAccession="NR_037946" sequenceVersion="1" change="n.3029_3033del">
            <Expression>NR_037946.1:n.3029_3033del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122955.4" sequenceAccession="NM_001122955" sequenceVersion="4" change="c.509_513del" MANESelect="true">
            <Expression>NM_001122955.4:c.509_513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116427.1" sequenceAccession="NP_001116427" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001116427.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130702.2" sequenceAccession="NM_001130702" sequenceVersion="2" change="c.317_321del">
            <Expression>NM_001130702.2:c.317_321del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124174.2" sequenceAccession="NP_001124174" sequenceVersion="2" change="p.Tyr106fs">
            <Expression>NP_001124174.2:p.Tyr106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386027.1" sequenceAccession="NM_001386027" sequenceVersion="1" change="c.509_513del">
            <Expression>NM_001386027.1:c.509_513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372956.1" sequenceAccession="NP_001372956" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001372956.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386028.1" sequenceAccession="NM_001386028" sequenceVersion="1" change="c.509_513del">
            <Expression>NM_001386028.1:c.509_513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372957.1" sequenceAccession="NP_001372957" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001372957.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.317_321del">
            <Expression>NM_032667.6:c.317_321del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116056.3" sequenceAccession="NP_116056" sequenceVersion="3" change="p.Tyr106fs">
            <Expression>NP_116056.3:p.Tyr106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_235" sequenceAccession="LRG_235">
            <Expression>LRG_235:g.19886_19890del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_235t1" sequenceAccession="LRG_235t1">
            <Expression>LRG_235t1:c.509_513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_235p1" sequenceAccession="LRG_235p1" change="p.Tyr170fs">
            <Expression>LRG_235p1:p.Tyr170fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_235t2" sequenceAccession="LRG_235t2">
            <Expression>LRG_235t2:c.317_321del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_235p2" sequenceAccession="LRG_235p2" change="p.Tyr106fs">
            <Expression>LRG_235p2:p.Tyr106fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.317_321delATCGT">
            <Expression>NM_032667.6:c.317_321delATCGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213090" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606158.0005" DB="OMIM" />
        <XRef Type="Allelic variant" ID="606158.0019" DB="OMIM" />
        <XRef Type="rs" ID="587777608" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs) AND Congenital generalized lipodystrophy type 2" Accession="RCV000004793" Version="6">
        <ClassifiedConditionList TraitSetID="1248">
          <ClassifiedCondition DB="MedGen" ID="C1720863">Congenital generalized lipodystrophy type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-12-26" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs) AND Severe neurodegenerative syndrome with lipodystrophy" Accession="RCV000133399" Version="6">
        <ClassifiedConditionList TraitSetID="16921">
          <ClassifiedCondition DB="MedGen" ID="C4014700">Severe neurodegenerative syndrome with lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs) AND not provided" Accession="RCV001091624" Version="20">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.509_513del (p.Tyr170fs) AND Berardinelli-Seip congenital lipodystrophy" Accession="RCV003311638" Version="2">
        <ClassifiedConditionList TraitSetID="50960">
          <ClassifiedCondition DB="MedGen" ID="CN262437">Berardinelli-Seip congenital lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-01-06" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-04-01" NumberOfSubmissions="5" NumberOfSubmitters="4" DateCreated="2015-05-08" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11479539</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18093937</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23564749</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301391</ID>
          <ID Source="BookShelf">NBK1212</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1248" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SEIP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 2</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+2/1830" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010020" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BERARDINELLI SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, BSCL2-RELATED</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CGL2</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10212" />
                <XRef ID="10212" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720863" DB="MedGen" />
              <XRef ID="MONDO:0010020" DB="MONDO" />
              <XRef Type="MIM" ID="269700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="50960" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42980" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Berardinelli-Seip congenital lipodystrophy</ElementValue>
                <XRef ID="GPDx_BSCL_BSCL2_001" DB="GenePathDx, GenePath diagnostics" />
                <XRef ID="MONDO:0018883" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BSCL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13388" />
                <XRef ID="13388" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="CN262437" DB="MedGen" />
              <XRef ID="MONDO:0018883" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16921" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="21315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Severe neurodegenerative syndrome with lipodystrophy</ElementValue>
                <XRef ID="MONDO:0014402" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY</ElementValue>
                <XRef Type="Allelic variant" ID="606158.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606158.0019" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, progressive, with or without lipodystrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PELD</ElementValue>
                <XRef Type="MIM" ID="615924" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families.</Attribute>
                <XRef ID="NBK1307" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17552" />
                <XRef ID="17552" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301484</ID>
                <ID Source="BookShelf">NBK1307</ID>
              </Citation>
              <XRef ID="363400" DB="Orphanet" />
              <XRef ID="C4014700" DB="MedGen" />
              <XRef ID="MONDO:0014402" DB="MONDO" />
              <XRef Type="MIM" ID="615924" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24969" SubmissionDate="2015-05-01" DateLastUpdated="2015-05-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606158.0005_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" title="BSCL2, 5-BP DEL, NT659_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" />
        <ClinVarAccession Accession="SCV000024969" DateUpdated="2015-05-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-12-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Magre et al. (2001) found that all Lebanese patients with Berardinelli-Seip congenital lipodystrophy (CGL2; 269700) whom they studied were homozygous for a frameshift mutation resulting from the deletion of GTATC at nucleotide 659 of the BSCL2 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">11479539</ID>
              </Citation>
              <XRef DB="OMIM" ID="269700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In fibroblasts from a BSCL2 patient with the 5-bp deletion, Szymanski et al. (2007) found abnormal cytoplasmic lipid droplets.</Attribute>
              <Citation>
                <ID Source="PubMed">18093937</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <Name>BSCL2, 5-BP DEL, NT659</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, NT659</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606158.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="311844" SubmissionDate="2018-08-09" DateLastUpdated="2018-08-12" DateCreated="2014-08-18">
        <ClinVarSubmissionID localKey="606158.0019_ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY" title="BSCL2, 5-BP DEL, NT507_ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY" />
        <ClinVarAccession Accession="SCV000188472" DateUpdated="2018-08-12" DateCreated="2014-08-18" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old girl from Murcia, Spain, with autosomal recessive progressive encephalopathy with lipodystrophy (PELD; 615924), Guillen-Navarro et al. (2013) identified compound heterozygous mutations in the BSCL2 gene: a 5-bp deletion (c.507_511del), resulting in a frameshift and premature termination (Tyr170CysfsTer6), and a c.985C-T transition (606158.0017), resulting in premature termination. Each unaffected parent was heterozygous for 1 of the mutations. The patient had 2 uncles with a similar disorder, who both died in childhood; DNA was not available from these patients, but analysis of their unaffected parents showed that each was heterozygous for 1 of the mutations found in the girl, suggesting that the uncles were compound heterozygous for the mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">23564749</ID>
              </Citation>
              <XRef DB="OMIM" ID="615924" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <Name>BSCL2, 5-BP DEL, NT507</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, NT507</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606158.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="957409" SubmissionDate="2016-12-08" DateLastUpdated="2022-10-01" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_032667.5:c.317_321delATCGT|OMIM:269700" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000490132" DateUpdated="2022-10-01" DateCreated="2015-10-11" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1212</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_116056.3:p.Tyr106CysfsTer6</Name>
            <Name>c.del659_663</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.5:c.317_321delATCGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720863" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7508476" SubmissionDate="2023-06-02" DateLastUpdated="2023-07-16" DateCreated="2023-07-16">
        <ClinVarSubmissionID localKey="NM_032667.6:c.317_321delATCGT|Orphanet:528" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004011973" DateUpdated="2023-07-16" DateCreated="2023-07-16" Type="SCV" Version="1" SubmitterName="Inherited Neuropathy Consortium Ii, University Of Miami" OrgID="508951" OrganizationCategory="consortium" OrgAbbreviation="Lab-SZU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11479539</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.6:c.317_321delATCGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA528" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13361505</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2469372" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="102619|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001247773" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CACGAT" start="62462156" stop="62462161" variantLength="6" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="957409" TraitType="Disease" MappingType="XRef" MappingValue="C1720863" MappingRef="MedGen">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7508476" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA528" MappingRef="Orphanet">
        <MedGen CUI="CN262437" Name="Berardinelli-Seip congenital lipodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24969" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2469372" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="311844" TraitType="Disease" MappingType="Name" MappingValue="ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY" MappingRef="Preferred">
        <MedGen CUI="C4014700" Name="Severe neurodegenerative syndrome with lipodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

